南京三迭纪医药科技有限公司

Founded in July 2015, Triastek is dedicated to the mission of。 Global leader in 3D printing pharmaceuticals Pioneer of new digital pharmaceutical processes。 Founded in July 2015, Triastek is dedicated to the mission of “revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide. “ We have created the Melt Extrusion Deposition (MED®) 3D printing pharmaceutical process, transforming the delivery, development, and production of medicines through digital product development and continuous manufacturing. Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medicines for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation problems, accelerating the development of new drug products and improving the quality of pharmaceuticals.